Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 23265145)

1.

Methylnaltrexone for the treatment of opioid-induced constipation.

Bader S, Dürk T, Becker G.

Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):13-26. doi: 10.1586/egh.12.63. Review.

PMID:
23265145
3.

Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Gatti A, Sabato AF.

Clin Drug Investig. 2012 May 1;32(5):293-301. doi: 10.2165/11598000-000000000-00000. Review.

PMID:
22413747
4.

[Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].

Chappell D, Conzen P.

Schmerz. 2009 Oct;23(5):471-8. doi: 10.1007/s00482-009-0824-3. Review. German.

PMID:
19690895
5.

Methylnaltrexone for opioid-induced constipation in advanced illness.

Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.

N Engl J Med. 2008 May 29;358(22):2332-43. doi: 10.1056/NEJMoa0707377.

6.

Methylnaltrexone: treatment for opioid-induced constipation.

Licup N, Baumrucker SJ.

Am J Hosp Palliat Care. 2011 Feb;28(1):59-61. doi: 10.1177/1049909110373507. Epub 2010 Aug 27. Review.

PMID:
20801917
7.

Methylnaltrexone: MNTX.

[No authors listed]

Drugs R D. 2006;7(6):374-8. Review.

PMID:
17073520
8.

Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.

Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.

J Pain Symptom Manage. 2009 Nov;38(5):683-90. doi: 10.1016/j.jpainsymman.2009.02.234. Epub 2009 Aug 26.

PMID:
19713070
9.

The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.

Leppert W.

Adv Ther. 2010 Oct;27(10):714-30. doi: 10.1007/s12325-010-0063-0. Epub 2010 Aug 26. Review.

PMID:
20799006
10.

Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.

Yuan CS.

J Support Oncol. 2004 Mar-Apr;2(2):111-7; discussion 119-22. Review.

PMID:
15328815
11.

Pharmacologic treatment of opioid-induced constipation.

Wang CZ, Yuan CS.

Expert Opin Investig Drugs. 2013 Oct;22(10):1225-7. doi: 10.1517/13543784.2013.819341. Epub 2013 Jul 9.

PMID:
23834367
12.

Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.

Diego L, Atayee R, Helmons P, von Gunten CF.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):473-85. doi: 10.1586/egh.09.42. Review.

PMID:
19817669
13.

Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.

Rauck RL.

Drugs. 2013 Aug;73(12):1297-306. doi: 10.1007/s40265-013-0084-5. Review.

PMID:
23881667
14.

Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.

J Support Oncol. 2009 Jan-Feb;7(1):39-46.

PMID:
19278178
15.

Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.

Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.

J Pain Palliat Care Pharmacother. 2011;25(2):136-45. doi: 10.3109/15360288.2011.573531.

PMID:
21657861
16.

Methylnaltrexone: the answer to opioid-induced constipation?

Cannom RR, Mason RJ.

Expert Opin Pharmacother. 2009 Apr;10(6):1039-45. doi: 10.1517/14656560902833914 . Review.

PMID:
19364251
17.

Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.

Lee JM, Mooney J.

Clin J Pain. 2012 May;28(4):338-41. doi: 10.1097/AJP.0b013e31822ad94c.

PMID:
21876436
18.

Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.

Iyer SS, Randazzo BP, Tzanis EL, Schulman SL, Zhang H, Wang W, Manley AL.

Value Health. 2011 Jan;14(1):177-83. doi: 10.1016/j.jval.2010.11.003.

PMID:
21211500
19.

Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.

Slatkin NE, Lynn R, Su C, Wang W, Israel RJ.

J Pain Symptom Manage. 2011 Nov;42(5):754-60. doi: 10.1016/j.jpainsymman.2011.02.015.

PMID:
22045373
20.

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

Michna E, Blonsky ER, Schulman S, Tzanis E, Manley A, Zhang H, Iyer S, Randazzo B.

J Pain. 2011 May;12(5):554-62. doi: 10.1016/j.jpain.2010.11.008. Epub 2011 Mar 22.

PMID:
21429809
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk